go grey glp 1 Analysis: GLP-1s and Mortality Risk I'm stuck in the gray

Ongoing treatment is required

Anti wrinkle injections are well-established and considered low-risk when performed by appropriately trained clinicians

The WHO December 2025 guideline and what it means for BMI thresholds In December 2025, the World Health Organization released its first-ever guideline on the use of GLP-1 therapies for treating obesity in adults

Global NASH Council, American Association for the Study of Liver Diseases (AASLD), EASL | The Home of Hepatology, Canadian Association for the Study of the Liver, European Liver Patients' Association - ELPA, Global Liver Institute, Priti Chawla, Obesity Matters, American Diabetes Association Fatty Liver Alliances Post GLP-1 receptor agonists (GLP-1RAs) show promise in managing metabolic dysfunction-associated steatotic liver disease (MASLD) by reducing hepatic steatosis, resolving MASH, and mitigating fibrosis progression

Get rid of toxic cosmetics and other body products: Choose the chemical-free range of products for your body care regimen